Dashboard
Manage Tickers

GILDGILEAD SCIENCES, INC.

Nasdaq gilead.com


$ 74.75 $ 0.30 (0.4 %)    

Tuesday, 20-Aug-2024 15:59:57 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 480.15 $ -1.01 (-0.21 %)
DIA $ 408.54 $ -0.55 (-0.13 %)
SPY $ 558.65 $ -0.91 (-0.16 %)
TLT $ 98.68 $ 0.78 (0.8 %)
GLD $ 232.46 $ 0.85 (0.37 %)
$ 74.75
$ 74.42
$ 74.74 x 200
$ 74.76 x 100
$ 74.32 - $ 74.89
$ 61.32 - $ 85.92
3,631,708
na
93.51B
$ 0.31
$ 88.72
TBD
na
na ($ 0.04)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-08-2024 06-30-2024 10-Q
2 05-08-2024 03-31-2024 10-Q
3 02-23-2024 12-31-2023 10-K
4 11-07-2023 09-30-2023 10-Q
5 08-04-2023 06-30-2023 10-Q
6 05-03-2023 03-31-2023 10-Q
7 02-22-2023 12-31-2022 10-K
8 11-02-2022 09-30-2022 10-Q
9 08-08-2022 06-30-2022 10-Q
10 05-04-2022 03-31-2022 10-Q
11 02-23-2022 12-31-2021 10-K
12 11-03-2021 09-30-2021 10-Q
13 08-05-2021 06-30-2021 10-Q
14 05-06-2021 03-31-2021 10-Q
15 02-25-2021 12-31-2020 10-K
16 11-04-2020 09-30-2020 10-Q
17 08-06-2020 06-30-2020 10-Q
18 05-06-2020 03-31-2020 10-Q
19 02-25-2020 12-31-2019 10-K
20 11-05-2019 09-30-2019 10-Q
21 08-06-2019 06-30-2019 10-Q
22 05-08-2019 03-31-2019 10-Q
23 02-26-2019 12-31-2018 10-K
24 11-06-2018 09-30-2018 10-Q
25 08-06-2018 06-30-2018 10-Q
26 05-09-2018 03-31-2018 10-Q
27 02-27-2018 12-31-2017 10-K
28 11-07-2017 09-30-2017 10-Q
29 08-07-2017 06-30-2017 10-Q
30 05-10-2017 03-31-2017 10-Q
31 02-27-2017 12-31-2016 10-K
32 11-07-2016 09-30-2016 10-Q
33 08-05-2016 06-30-2016 10-Q
34 05-06-2016 03-31-2016 10-Q
35 02-24-2016 12-31-2015 10-K
36 11-04-2015 09-30-2015 10-Q
37 08-05-2015 06-30-2015 10-Q
38 05-08-2015 03-31-2015 10-Q
39 02-25-2015 12-31-2014 10-K
40 11-05-2014 09-30-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

peering-into-gilead-sciencess-recent-short-interest
Peering Into Gilead Sciences's Recent Shor...
08/20/2024 16:00:15

pantherx-rare-partnering-with-gilead-sciences-for-distribution-of-livdelzi
Pantherx Rare Partnering With Gilead Scien...
08/16/2024 15:38:41

- Reuters 

gileads-ongoing-battle-against-counterfeit-hiv-medications-persists-with-new-lawsuit-seizes-750k-in-fake-drugs
Gilead's Ongoing Battle Against Counterfei...
08/16/2024 15:24:48

Gilead Sciences exposes a major counterfeiting ring led by Peter Khaim, involving tampered HIV medications resold from New York...

truist-securities-maintains-hold-on-gilead-sciences-raises-price-target-to-83
Truist Securities Maintains Hold on Gilead...
08/15/2024 13:09:45

Truist Securities analyst Robyn Karnauskas maintains Gilead Sciences (NASDAQ:GILD) with a Hold and raises the price target f...

fda-approves-gileads-seladelpar-for-inflammatory-liver-disease-acquired-via-4b-cymabay-deal
FDA Approves Gilead's Seladelpar For Infla...
08/15/2024 13:09:17

FDA grants accelerated approval to Gilead's Livdelzi (seladelpar) for primary biliary cholangitis, offering new treatment o...

expert-outlook-gilead-sciences-through-the-eyes-of-8-analysts
Expert Outlook: Gilead Sciences Through Th...
08/15/2024 13:00:37

needham-reiterates-hold-on-gilead-sciences
Needham Reiterates Hold on Gilead Sciences
08/15/2024 11:34:57

Needham analyst Joseph Stringer reiterates Gilead Sciences (NASDAQ:GILD) with a Hold.

fda-approves-gileads-livdelzi-for-primary-biliary-cholangitis
FDA Approves Gilead's Livdelzi For Primary...
08/14/2024 17:03:30

- Reuters Citing Co Website

rbc-capital-maintains-sector-perform-on-gilead-sciences-raises-price-target-to-72
RBC Capital Maintains Sector Perform on Gi...
08/09/2024 19:25:24

RBC Capital analyst Brian Abrahams maintains Gilead Sciences (NASDAQ:GILD) with a Sector Perform and raises the price target...

analysts-cite-improved-investor-sentiment-for-gilead-but-warn-of-limited-growth-at-current-stock-levels
Analysts Cite Improved Investor Sentiment ...
08/09/2024 17:48:23

Gilead Sciences' Q2 2024 revenue rose to $6.95B, beating expectations, driven by strong performance in HIV, Liver Disease, ...

wall-street-momentum-stalls-after-thursdays-rally-palantir-jumps-to-3-year-highs-bonds-rally-whats-driving-markets-friday
Wall Street Momentum Stalls After Thursday...
08/09/2024 17:13:36

After a blistering Thursday that saw the S&P 500 close with its best session in nearly two years — up 2.3% — Wall Street’s ...

cantor-fitzgerald-reiterates-neutral-on-gilead-sciences-maintains-70-price-target
Cantor Fitzgerald Reiterates Neutral on Gi...
08/09/2024 15:36:11

Cantor Fitzgerald analyst Olivia Brayer reiterates Gilead Sciences (NASDAQ:GILD) with a Neutral and maintains $70 price target.

bmo-capital-maintains-outperform-on-gilead-sciences-raises-price-target-to-85
BMO Capital Maintains Outperform on Gilead...
08/09/2024 11:53:49

BMO Capital analyst Evan Seigerman maintains Gilead Sciences (NASDAQ:GILD) with a Outperform and raises the price target fro...

gilead-sciences-raises-fy24-adj-eps-forecast-from-345---385-to-360---390-est-375-product-sales-outlook-unchanged
Gilead Sciences Raises FY24 Adj EPS Foreca...
08/08/2024 20:25:48

gilead-sciences-q2-2024-adj-eps-201-beats-160-estimate-sales-6954b-beat-6719b-estimate
Gilead Sciences Q2 2024 Adj. EPS $2.01 Bea...
08/08/2024 20:03:06

Gilead Sciences (NASDAQ:GILD) reported quarterly earnings of $2.01 per share which beat the analyst consensus estimate of $1.60...

wall-street-rallies-as-economic-concerns-recede-tech-flexes-its-muscles-semiconductors-soar-whats-driving-markets-thursday
Wall Street Rallies As Economic Concerns R...
08/08/2024 17:19:57

Investor risk sentiment is showing greater conviction on Thursday, with all indices and major stock sectors in the green, after...

wall-street-set-for-uneventful-start-ahead-of-jobless-claim-data-vix-rises-strategist-says-market-may-remain-vulnerable-until
Wall Street Set For Uneventful Start Ahead...
08/08/2024 11:50:25

U.S. stocks are set for a mixed start on Thursday as concerns regarding the economy and incremental yen carry trade unwinding r...

1000-invested-in-gilead-sciences-20-years-ago-would-be-worth-this-much-today
$1000 Invested In Gilead Sciences 20 Years...
08/06/2024 16:00:21

gilead-sciencess-options-frenzy-what-you-need-to-know
Gilead Sciences's Options Frenzy: What You...
07/30/2024 18:01:50

100-invested-in-gilead-sciences-20-years-ago-would-be-worth-this-much-today
$100 Invested In Gilead Sciences 20 Years ...
07/29/2024 19:02:38

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION